華人健康(301408.SZ):擬購買揚祖惠民46.01%股權、海華醫藥46.01%股權及桐廬怡生堂70.01%股權
格隆匯5月21日丨華人健康(301408.SZ)公佈,公司(“受讓方”)擬通過支付現金方式購買寧波閩哲匯投資合夥企業(有限合夥)(以下簡稱“閩哲匯”或“交易對方”或“轉讓方”)持有的福建省揚祖惠民醫藥連鎖有限公司(以下簡稱“揚祖惠民”或“目標公司一”)46.01%的股權、購買閩哲匯持有的福建海華醫藥連鎖有限公司(以下簡稱“海華醫藥”或“目標公司二”)46.01%的股權及購買閩哲匯持有的桐廬怡生堂大藥房連鎖有限公司(以下簡稱“桐廬怡生堂”或“目標公司三”)70.01%的股權(以下合稱“本次交易”或“本次收購”)。本次交易,公司計劃使用自有資金及變更部分募集資金用途進行支付,若變更募集資金用途的審覈未獲批準,公司將全部使用自有資金支付。
本次交易目標公司揚祖惠民46.01%股權的交易價格爲1.33億元。本次交易目標公司海華醫藥46.01%股權的交易價格爲1.25億元。本次交易目標公司桐廬怡生堂70.01%股權的交易價格爲6,825.975萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.